• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Change of macrophage migration inhibitory factor: possible indicator for postoperative prognosis.

作者信息

Orita K, Mannami T, Yumura M, Hayashi S, Miwa H

出版信息

Jpn J Surg. 1977 Sep;7(3):118-22. doi: 10.1007/BF02469341.

DOI:10.1007/BF02469341
PMID:336944
Abstract

Sixty three cancer cases who received minimum of the removal of the main tumor constitute the subjects of the present study. Macrophage migration inhibitory factor (MIF) of peripheral blood lymphocytes was studied using extirpated autochthonous tumor tissues as antigen and guinea-pig peritoneal exudative cells as indicator cells immediately before the operation and the fourth postoperative week. The results indicated that in those cases of relatively early stage, i.e. Stages I and II, whose tumor was believed to have been removed completely, MIF turned negative in 7/9 (77.8 per cent) after the operation, while in others with advanced cancer of Stage IV in which the tumor bearing tissue was probably not completely removed, MIF turned positive in most cases (13/17: 75.6 per cent) postoperatively, even though it was negative before the operation. In the cases of Stage III with cancer progressed to an intermediate degree, in about half of the cases (7/11: 63.6 per cent) MIF turned negative after the operation and in the other half (7/10: 70 per cent) MIF became positive postoperatively, suggesting that for MIF to persist the presence of certain amount of tumor tissue is necessary.

摘要

相似文献

1
Change of macrophage migration inhibitory factor: possible indicator for postoperative prognosis.
Jpn J Surg. 1977 Sep;7(3):118-22. doi: 10.1007/BF02469341.
2
Lymphokines. II. Use of horse monocytes as indicator cells for human MIF.淋巴因子。II. 用马单核细胞作为人巨噬细胞移动抑制因子的指示细胞
Int Arch Allergy Appl Immunol. 1976;50(2):142-54.
3
Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.豚鼠体内细胞介导免疫反应产生的巨噬细胞移动抑制因子活性的特性分析。
J Immunol. 1976 Nov;117(5 Pt 1):1716-20.
4
Mechanism of action of migration inhibitory factor (MIF). I. Evidence for a receptor for MIF present on the peritoneal macrophage but not on the alveolar macrophage.迁移抑制因子(MIF)的作用机制。I. 腹膜巨噬细胞存在MIF受体而肺泡巨噬细胞不存在该受体的证据。
J Exp Med. 1972 Sep 1;136(3):589-603. doi: 10.1084/jem.136.3.589.
5
Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.体外产生豚鼠迁移抑制因子(MIF)对巨噬细胞的需求。
J Immunol. 1975 Feb;114(2 Pt 1):606-9.
6
A rapid method for measuring the production of human migration inhibitory factor (MIF).
Cell Immunol. 1974 Jun;12(3):481-6. doi: 10.1016/0008-8749(74)90104-x.
7
Macrophage migration inhibition factor (MIF): reducing the variables.巨噬细胞移动抑制因子(MIF):减少变量
J Immunol Methods. 1982;52(1):127-36. doi: 10.1016/0022-1759(82)90358-1.
8
Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.豚鼠淋巴细胞源性巨噬细胞聚集因子:其与巨噬细胞移动抑制因子的分离
J Immunol. 1976 Nov;117(5 Pt 1):1651-5.
9
Possible role of macrophage glycolipids as receptors for migration inhibitory factor (MIF).巨噬细胞糖脂作为迁移抑制因子(MIF)受体的潜在作用。
J Immunol. 1978 Sep;121(3):880-6.
10
Functional activation of immune lymphocytes by antigenic stimulation in cell-mediated immunity. IV. Role of macrophage and its soluble factor in antigen-induced MIF production of immune T lymphocytes.细胞介导免疫中抗原刺激对免疫淋巴细胞的功能激活。IV. 巨噬细胞及其可溶性因子在抗原诱导免疫T淋巴细胞产生巨噬细胞移动抑制因子中的作用。
J Immunol. 1979 Mar;122(3):942-8.

本文引用的文献

1
In vitro cell migration as a model for delayed hypersensitivity.体外细胞迁移作为迟发型超敏反应的模型。
Proc Soc Exp Biol Med. 1962 Nov;111:514-21. doi: 10.3181/00379727-111-27841.
2
A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas.癌症、白血病、霍奇金病及其他淋巴瘤患者无反应性发生率的比较研究。
J Immunol. 1962 Oct;89:555-8.
3
The inhibitory influence of a transplanted hamster lymphoma on metastasis.移植的仓鼠淋巴瘤对转移的抑制作用。
Cancer Res. 1960 Aug;20:1094-100.
4
Symposium: Blood culture and its biological significance. Reaction of the lymphoid cells on target cells in vitro.
Nihon Ketsueki Gakkai Zasshi. 1968 Oct;31(5):697-709.
5
Effect of autologous mammary tumour extracts on human leukocyte migration in vitro.自体乳腺肿瘤提取物对人白细胞体外迁移的影响。
Int J Cancer. 1970 May 15;5(3):357-63. doi: 10.1002/ijc.2910050308.
6
Impaired immunologic reactivity and recurrence following cancer surgery.癌症手术后免疫反应受损与复发
Cancer. 1970 Feb;25(2):362-7. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v.
7
The association of immune disease and malignant lymphoma.免疫性疾病与恶性淋巴瘤的关联。
Ann Intern Med. 1967 Mar;66(3):507-21. doi: 10.7326/0003-4819-66-3-507.
8
Immunologic defenses against metastases: impairment by excision of an allotransplanted lymphoma.针对转移的免疫防御:同种异体移植淋巴瘤切除所致的损害
Science. 1968 Feb 9;159(3815):646-8. doi: 10.1126/science.159.3815.646.
9
Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.携带不同大小同基因纤维肉瘤的C3Hf-Bu小鼠对肺转移的免疫抗性
Cancer Res. 1974 Jan;34(1):61-71.
10
Immunologic abnormalities in head and neck cancer.头颈癌中的免疫异常
Am J Surg. 1974 Oct;128(4):534-8. doi: 10.1016/0002-9610(74)90269-4.